The US is the bigger Plant-Based Supplements market: $5.2 Bn against $989 Mn in 2023, about 5.2 times as large.
China grows faster: 9.5% a year, against 6%. The gap still grows from $4.2 Bn to $6.8 Bn by 2033.
Clinical research: 37 active trials in the US, 3 in China.
| Measure |  US |  China |
|---|---|---|
| Market size, 2023 | $5.2 Bn | $989 Mn |
| Market size, 2033 projected | $9.3 Bn | $2.5 Bn |
| Growth a year (CAGR) | 6% | 9.5% |
| Money added, 2023–2033 | $4.1 Bn | $1.5 Bn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $15 | $0.70 |
| Active clinical trials | 37 | 3 |
| Full report | US report | China report |
Year by year, 2023 to 2033
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Plant-Based Supplements, US or China?
The US is the bigger Plant-Based Supplements market: $5.2 Bn against $989 Mn in 2023, about 5.2 times as large.
Which grows faster in Plant-Based Supplements, US or China?
China grows faster: 9.5% a year, against 6%. The gap still grows from $4.2 Bn to $6.8 Bn by 2033.
More Plant-Based Supplements comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.